Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
10.21
+0.09 (0.89%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.65 billion as of September 26, 2025. Its market cap has decreased by -48.86% in one year.
Market Cap
2.65B
Enterprise Value
10.95B
1-Year Change
-48.86%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.65B, a decrease of -68.46%. That is a compound annual growth rate of -23.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.65B | -30.92% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |